Damora Therapeutics, Inc. (DMRA)
24.88
+0.04
(+0.16%)
USD |
NASDAQ |
May 29, 16:00
24.88
0.00 (0.00%)
After-Hours: 20:00
Damora Therapeutics EPS Diluted (Quarterly) : -0.8092 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.8785 |
| Incyte Corp. | 1.467 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.78M |
| Total Expenses (Quarterly) | 27.78M |
| Enterprise Value | 1.131B |
| Earnings Yield | -13.70% |